Literature DB >> 2376088

Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients.

S Arthur1, A Greenberg.   

Abstract

Three renal transplant recipients developed potentially life-threatening hyperkalemia after receiving intravenous labetalol for postoperative hypertension. Even as beta-adrenergic agonists find increasing use in the therapy of acute hyperkalemia, physicians should be aware of the potential of beta blockers to cause profound elevations of serum potassium.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2376088

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


  4 in total

1.  Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Authors:  Matthew A Weir; David N Juurlink; Tara Gomes; Muhammad Mamdani; Daniel G Hackam; Arsh K Jain; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 2.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

3.  Differential diagnosis of hyperkalemia: an update to a complex problem.

Authors:  T Eleftheriadis; K Leivaditis; G Antoniadi; V Liakopoulos
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

4.  Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol.

Authors:  S Serge Barold; Scott Upton
Journal:  Case Rep Cardiol       Date:  2018-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.